Skip to main content
Erschienen in: Intensive Care Medicine 2/2009

Open Access 01.02.2009 | Experimental

High versus standard-volume haemofiltration in hyperdynamic porcine peritonitis: effects beyond haemodynamics?

verfasst von: Roman Sykora, Jiri Chvojka, Ales Krouzecky, Jaroslav Radej, Thomas Karvunidis, Veronika Varnerova, Ivan Novak, Martin Matejovic

Erschienen in: Intensive Care Medicine | Ausgabe 2/2009

Abstract

Objective

The role of haemofiltration as an adjunctive treatment of sepsis remains a contentious issue. To address the role of dose and to explore the biological effects of haemofiltration we compared the effects of standard and high-volume haemofiltration (HVHF) in a peritonitis-induced model of porcine septic shock.

Design and setting

Randomized, controlled experimental study.

Subjects

Twenty-one anesthetized and mechanically ventilated pigs.

Interventions

After 12 h of hyperdynamic peritonitis, animals were randomized to receive either supportive treatment (Control, n = 7) or standard haemofiltration (HF 35 ml/kg per h, n = 7) or HVHF (100 ml/kg per hour, n = 7).

Measurements and results

Systemic and hepatosplanchnic haemodynamics, oxygen exchange, energy metabolism (lactate/pyruvate, ketone body ratios), ileal and renal cortex microcirculation and systemic inflammation (TNF-α, IL-6), nitrosative/oxidative stress (TBARS, nitrates, GSH/GSSG) and endothelial/coagulation dysfunction (von Willebrand factor, asymmetric dimethylarginine, platelet count) were assessed before, 12, 18, and 22 h of peritonitis. Although fewer haemofiltration-treated animals required noradrenaline support (86, 43 and 29% animals in the control, HF and HVHF groups, respectively), neither of haemofiltration doses reversed hyperdynamic circulation, lung dysfunction and ameliorated alterations in gut and kidney microvascular perfusion. Both HF and HVHF failed to attenuate sepsis-induced alterations in surrogate markers of cellular energetics, nitrosative/oxidative stress, endothelial injury or systemic inflammation.

Conclusions

In this porcine model of septic shock early HVHF proved superior in preventing the development of septic hypotension. However, neither of haemofiltration doses was capable of reversing the progressive disturbances in microvascular, metabolic, endothelial and lung function, at least within the timeframe of the study and severity of the model.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1007/​s00134-008-1318-y) contains supplementary material, which is available to authorized users.
Roman Sykora and Jiri Chvojka contributed equally to this study.

Introduction

Extracorporeal blood purification techniques as an adjunctive treatment of sepsis in critically ill patients remain a conceptually sound but still unresolved issue [13]. Haemofiltration, which is nowadays one of the most widely used hemopurification method in the ICU, failed to significantly reduce plasma cytokine concentrations and ameliorate organ dysfunction in septic patients when low ultrafiltration doses (2 l/h of plasma water exchange) were used [4]. In contrast, the importance of dialysis intensity to improve the outcome of critically ill patients with acute renal failure has been demonstrated [57]. Nonetheless, although the minimal ultrafiltration rate of 35 ml/kg per hour has been recommended [1, 3], recent large multicenter trial, in which 63% of patients were septic, challenged the issue of a dosage-outcome relationship in patients with acute kidney injury [8]. In addition, Ronco et al. [5] suggested a beneficial trend in survival when further increasing the dose of haemofiltration up to 45 ml/kg per hour in a small subgroup of septic patients. Although limited in their robustness and methodological aspects, several human [915] and animal [1620] studies further support the concept of high-volume haemofiltration (HVHF) in the treatment of endotoxemia or septic shock, mainly by demonstrating a reduced need for vasopressors dose and better hemodynamic stability. However, human studies were either uncontrolled or retrospective, thereby limiting the inference that could be drawn [21]. Similarly, the clinical relevance of some experimental studies focusing predominantly on haemodynamics, gas exchange, plasma cytokine levels, immunoparalysis and short-term survival, is limited by the fact that (1) haemofiltration was started before, during or very early after the septic or endotoxemic insult [21]; (2) the treatment effects were investigated mostly in hypodynamic models characterized by hypotension and low cardiac output, which is in contrast to the hyperdynamic pattern commonly seen in patients with septic shock. Finally, all studies compared the effects of HVHF either with untreated subjects or with low volume haemofiltration (i.e. 20 ml/kg per hour); hence, it is unknown whether increasing the dose of plasma water exchange confers an additional benefit over currently accepted standard haemofiltration dose (i.e. 35 ml/kg per hour). Therefore, to further explore the biological effects of haemofiltration and the role of its dose in sepsis, we investigated (1) the impact of haemofiltration on regional and microcirculatory perfusion, energy metabolism, oxidative stress, endothelial dysfunction and systemic inflammatory response in a porcine model of hyperdynamic fecal peritonitis-induced septic shock that integrates standard day-to-day care resuscitative measures; (2) whether increasing haemofiltration dose from standard (35 ml/kg per hour) to high volume (100 ml/kg per hour) provides an additional benefit.

Material and methods

The experiment was performed in adherence to the National Institutes of Health Guidelines on the Use of Laboratory Animals. The study protocol was approved by the University Animal Care Committee. Twenty-one anesthetized and ventilated pigs of either gender with a body weight [median (quartiles): 38 kg (34, 42)] were investigated. The anesthesic procedure, surgical instrumentation, and physiological measurements were performed as recently described (see the Electronic supplement material for details) [2224]. Hemodynamic parameters recorded over a period of 22 h comprised mean arterial pressure, cardiac output, intrathoracic blood volume (ITBV), filling pressures, portal venous, hepatic and renal arterial blood flows. Microvascular measurements included ileal mucosal and renal cortex microvascular perfusion [laser Doppler flowmetry and the Side-stream Dark Field (SDF) imaging] [2226]. Arterial, portal, hepatic and renal venous lactate (L) and pyruvate (P) concentrations, arterial serum levels of alanine aminotransferase (ALT), the hepatic venous ketone body ratio (KBR, acetoacetate/β-hydroxybutyrate), arterial thiobarbituric acid reactive species (TBARS), reduced and oxidized glutathione (GSH/GSSG), and nitrate + nitrite (NOx) concentrations were measured. From arterial blood samples we also assessed von Willebrand factor (vWF), platelet count, asymmetric dimethylarginine (ADMA), tumor necrosis factor alpha (TNF-α), and interleukin 6 (IL-6). To correct for dilutional effects resulting from volume resuscitation NOx, TBARS, ADMA, ALT, vWF, IL-6 and TNF-α levels were normalized for plasma protein content [2224]. Finally, ultrafiltrate TNF-α and IL-6 concentrations were analyzed.

Haemofiltration setting

The zero-balanced haemofiltration was performed on the MultiFiltrate system (Fresenius Medical Care AG & Co. KGaA, Bad Homburg, Germany) with a synthetic membrane (Ultraflux AV600S; the high-flux polysulphon filter, surface 1.4 m2, cut off up to 30,000 Da, Fresenius). Blood flow rate was set at 200 ml/min. Bicarbonate buffered (35 mmol/l) replacement fluid (Medisol Bi-4, solution for haemofiltration, Medites Pharma, Roznov pod Radhostem, Czech Republic) was administered 50% in predilution and 50% in postdilution fashion. The replacement fluid was warmed to 39°C in the MultiFiltrate, and the HOTLINE® Blood and Fluid Warmer (Smiths Medical, UK) was inserted on the venous return line to prevent an extracorporeal circuit-induced decrease in body temperature. Anticoagulation was achieved with an initial i.v. bolus 0.2 ml/10 kg of nadroparinum (Fraxiparine, Glaxo Group Ltd, Greenford, Middlesex, UK) for all experimental animals, including the control group.

Protocol

After baseline data measurements, peritonitis was induced by inoculating 0.5 g/kg of autologous feces suspended in 200 ml saline into the abdominal cavity through the drainage tubes. A second set of measurements was obtained after 12 h of peritonitis induction. Then, the pigs were randomly divided into three groups: control animals (CON n = 7), animals receiving continuous haemofiltration at standard ultrafiltration rate of 35 ml/kg per hour (HF n = 7) and animals treated by HVHF at an ultrafiltration rate of 100 ml/kg per hour (HVHF n = 7). Further measurements were recorded at 18 and 22 h of peritonitis. In addition to the Plasma Lyte solution, 6% hydroxyethyl starch 130 kDa/0.4 (Voluven 6%, Fresenius Kabi Deutschland GmbH, Bad Homburg, Germany) was infused at a rate of 10 ml/kg per hour; (7 ml/kg per hour if CVP or PAOP ≥18 mmHg) to maintain cardiac filling pressures ≥12 mmHg. Continuous i.v. noradrenaline was administered if mean arterial pressure (MAP) fell below 70 mmHg. The dose of noradrenaline was adjusted to maintain MAP 70–75 mmHg. Additional five sham-operated animals were subjected to the haemofiltration. When the last set of data had been obtained, the animals were euthanized by KCl injection under deep anesthesia. The protocol of the study is illustrated in electronic supplemental material (Fig. 1 ESM).

Statistical analysis

All values shown are median and interquartile range. After the exclusion of normality using the Kolmogorov–Smirnov test, differences within each group between values obtained before and after the induction of peritonitis were tested using the Friedman ANOVA on ranks and, subsequently, Dunn’s test for multiple comparisons with the Bonferroni’s correction. Differences between the groups were analyzed using the Kruskal–Wallis one-way analysis of variance on ranks.

Results

Systemic haemodynamics, oxygen exchange, acid–base data and metabolism

The cumulative amount of colloid infusion to maintain a comparable cardiac preload was not statistically different in the three groups [control group 167 (154; 186), HF group 194 (160; 210), HVHF 194 (159; 202) ml/kg]. Fluid resuscitation maintained ITBV and significantly increased filling pressures (data not shown) without intergroup differences. All pigs developed hyperdynamic circulation with high cardiac output and low systemic vascular resistance, not reversed by the treatment. Although not statistically significant, six animals (86%) in the control group received noradrenaline infusion, while three (43%) and two (29%) pigs required vasopressor support in the HF and HVHF groups, respectively (Fig. 1). In animals requiring vasopressor support, the median time to development of arterial hypotension was not different in all groups (control group 19 [18, 20], HF group 17 [17, 20], HVHF group 18 h [17, 19]) (Fig. 1). The increased cardiac output resulted in a significant rise of systemic oxygen delivery without intergroup differences, while systemic oxygen consumption did not change in any of the three groups over time. The decline in arterial pH and BE was less pronounced in both haemofiltration groups, although the intergroup difference did not reach statistical difference. A significant progressive deterioration of the PaO2/FiO2 ratio was observed in all groups, without intergroup differences. The arterial L/P ratio increased progressively in all three groups, again without intergroup differences. There were no significant differences in body core temperature between the groups over time (P = 0.079 at 22 h) (Table 1).
Table 1
Systemic haemodynamics, oxygen exchange, metabolism and temperature
 
Baseline
12 h
18 h
22 h
MAP (mmHg)
 CON
94 (89; 104)
93 (85; 102)
85 (80; 102)
76 (74; 92)a
 HF
84 (82; 96)
88 (84; 94)
92 (88; 103)
78 (71; 81)
 HVHF
94 (87; 100)
98 (84; 113)
91 (76; 98)
81 (72; 91)
CO (ml/kg)
 CON
70 (61; 88)
108 (94; 122)a
114 (107; 128)a
147 (99; 183)a
 HF
73 (72; 85)
125 (102; 131)a
129 (112; 134)a
136 (126.162)a
 HVHF
74 (68; 80)
106 (92; 117)a
111 (107; 135)a
131 (126.155)a
MPAP (mmHg)
 CON
26 (23; 27)
34 (30; 36)a
35 (34; 40)a
38 (36; 43)a
 HF
27 (25; 47)
30 (29; 48)a
34 (31; 67)a
34 (32; 59)a
 HVHF
25 (22; 29)
29 (27; 39)a
34 (31; 37)a
40 (31; 47)a
SVR (dyne s/cm−5)
 CON
2774 (2524; 2839)
1717 (1467; 1956)a
1361 (1068; 1837)a
851 (719; 1514)a
 HF
2201 (1914; 2889)
1275 (1191; 1964)a
1276 (1172; 1669)a
929 (858; 1276)a
 HVHF
2447 (2070; 2734)
1782 (1589; 2014)
1340 (1158; 1583)a
1161 (830; 1326)a
ITBV (ml/kg)
 CON
22 (19; 33)
25 (19; 31)
26 (21; 28)
22 (18; 30)
 HF
25 (20; 29)
30 (24; 30)
25 (21; 25)
26 (25; 27)
 HVHF
19 (17; 25)
24 (22; 26)
26 (21; 28)
27 (25; 28)
DO2 (ml/min per kg)
 CON
9 (8; 13)
15 (14; 18)a
16 (15; 20)a
24 (16; 24)a
 HF
10 (8; 11)
18 (12; 18)a
17 (16; 18)a
16 (15; 17)a
 HVHF
10 (9; 11)
15 (13; 15)a
14 (13; 15)a
15 (13; 16)a
VO2 (ml/min per kg)
 CON
5 (4; 6)
6 (5; 9)
6 (5; 7)
7 (6; 9)
 HF
5 (4; 6)
6 (4; 7)
6 (5; 7)
5 (5; 6)
 HVHF
4 (4; 5)
6 (5; 6)
5 (5; 6)
5 (5; 6)
Arterial pH
 CON
7.52 (7.50; 7.54)
7.47 (7.44; 7.49)a
7.45 (7.43; 7.50)a
7.36 (7.32; 7.41)a
 HF
7.50 (7.48; 7.54)
7.49 (7.46; 7.50)
7.48 (7.46; 7.49)
7.45 (7.40; 7.48)
 HVHF
7.53 (7.50; 7.55)
7.46 (7.43; 7.52)a
7.45 (7.43; 7.47)a
7.40 (7.36; 7.48)a
Base excess (mmol/l)
 CON
5.7 (4.5; 6.6)
5.5 (4.7; 5.9)
4.2 (2.5; 5.9)
1.4 (−1.5; 1.4)a
 HF
6.8 (5.2; 8.6)
7.2 (5.1; 8)
5.3 (3.4; 6.6)
4.4 (0.8; 5.8)a
 HVHF
7.9 (5.5; 8.4)
5.5 (3.9; 6.2)
4.3 (3.2; 4.9)
2 (1.3; 6.4)a
Core temperature (°C)
 CON
38.0 (37.0; 38.3)
40.2 (39.1; 41.3)a
39.6 (38.7; 40.3)
39.5 (38.0; 40.4)
 HF
38.2 (37.2; 39.3)
39.7 (39.0; 40.5)a
38.7 (38.0; 38.8)
38.5 (38.0; 38.8)
 HVHF
37.6 (35.3; 38.0)
39.6 (37.8; 39.8)a
37.7 (37.4; 38.1)
37.5 (37.4; 38.1)
Oxygenation index (PaO2/FiO2)
 CON
416 (345; 475)
409 (289; 490)
283 (267; 396)a
160 (94; 271)a
 HF
491 (439; 509)
365 (292; 445)a
349 (259; 454)a
238 (174; 294)a
 HVFH
467 (396; 495)
437 (360; 499)
289 (230; 347)a
156 (72; 321)a
Arterial lactate/pyruvate ratio
 CON
11 (7; 19)
18 (11; 22)
17 (15; 36)
31 (20; 46)a
 HF
12 (11; 14)
10 (7; 14)
9 (8; 20)
28 (19; 56)a
 HVFH
13 (11; 17)
15 (8; 29)
22 (14; 53)a
60 (29; 87)a
MAP mean arterial pressure, CO cardiac output, MPAP mean pulmonary artery pressure, SVR systemic vascular resistance, ITBV intrathoracic blood volume, DO 2 systemic oxygen delivery, VO 2 systemic oxygen uptake, CON control group, HF standard haemofiltration group, HVHF high-volume haemofiltration group
aSignificant difference within each group versus baseline (P < 0.05). Data are median and 25th and 75th quartiles

Regional haemodynamics, microcirculation, metabolism and organ function

While liver blood flow and liver oxygen delivery increased significantly in all three groups, liver oxygen uptake remained unchanged. Renal artery blood flow, oxygen delivery and consumption did not change over time in any of the experimental groups. Despite well-maintained regional blood flow both ileal mucosal and renal cortex microvascular perfusion, as assessed by laser Doppler flowmetry, fell progressively in the control and HVHF groups (Fig. 2). Although the decline in renal cortex perfusion did not reach statistical significance in the HF group, there were no significant intergroup differences between all groups at the end of the experiment (Fig. 2). Direct visualization of the ileal mucosal microcirculation was consistent with laser Doppler flowmetry: Side-stream Dark Field imaging showed well perfused villi before the induction of peritonitis, while the mean flow index deteriorated over time in all experimental groups without intergroup differences. Whereas the decrease in renal and hepatic venous pH was less pronounced in treated animals, neither of the haemofiltration doses significantly prevented sepsis-induced changes in the hepato-splanchnic L/P ratios and KBR (Fig. 3). The significant increase in serum ALT activity occurring in the control and HF animals did not reach any intergroup significance. As expected, both treatment modalities presented with lower levels in serum creatinine (Table 2).
Table 2
Regional haemodynamics, oxygen exchange, acid–base status and organ function
 
Baseline
12 h
18 h
22 h
Q liver (ml/kg per min)
 CON
27 (21; 28)
35 (31; 37)a
28 (27; 33)
24 (19; 28)
 HF
20 (20; 23)
30 (26; 38)
33 (26; 40)
29 (18; 38)
HVFH
27 (24; 29)
34 (27; 38)
34 (31; 42)
36 (26; 38)
 Liver DO2 (ml/min per kg)
 CON
1.8 (1.6; 2.2)
4.4 (4.1; 4.6)a
4.1 (3.6; 4.7)a
3.4 (2.9; 4.1)a
 HF
1.3 (1.0; 1.7)
4.1 (2.8; 4.4)a
3.9 (3.0; 4.7)a
3.3 (2.6; 4.1)a
 HVFH
1.9 (1.7; 2.2)
3.4 (3.3; 4.4)a
4.0 (3.5; 4.4)a
3.1 (2.9; 3.8)a
Liver VO2 (ml/min per kg)
 CON
1.0 (0.8; 1.1)
1.0 (0.6; 1.5)
1.1 (0.8; 1.2)
1.1 (1.0; 1.3)
 HF
0.8 (0.5; 0.9)
0.9 (0.7; 1.0)
0.9 (0.7; 1.1)
1.0 (0.8; 1.3)
 HVFH
0.7 (0.6; 0.8)
1.0 (0.8; 1.2)
0.8 (0.6; 1.0)
0.8 (0.7; 1.4)
pH HV
 CON
7.44 (7.43; 7.46)
7.38 (7.37; 7.42)a
7.39 (7.37; 7.41)a
7.31 (7.28; 7.36)a
 HF
7.42 (7.39; 7.47)
7.43 (7.40; 7.43)
7.41 (7.34; 7.43)
7.41 (7.35; 7.42)
 HVFH
7.45 (7.42; 7.49)
7.36 (7.34; 7.48)
7.40 (7.38; 7.42)
7.41 (7.35; 7.41)
Serum ALT levels (nkat/g protein)
 CON
12 (12; 15)
11 (11; 16)
12 (12; 18)a
19 (12; 19)a
 HF
12 (10; 13)
12 (11; 15)
15 (12; 16)a
14 (12; 17)a
 HVFH
15 (9; 16)
12 (11; 16)
13 (11; 16)
15 (10; 17)
Q renal artery (ml/kg per min)
 CON
6 (4; 6)
7 (5; 8)
7 (5; 7)
4 (4; 6)
 HF
5 (4; 6)
7 (6; 10)
6 (5; 8)
6 (4; 9)
 HVFH
7 (3; 9)
6 (3; 8)
4 (3; 9)
4 (2; 10)
Renal DO2 (ml/min per kg)
 CON
0.8 (0.6; 0.9)
1.1 (0.8; 1.2)
0.8 (0.7; 1.1)
0.6 (0.5; 1.1)
 HF
0.7 (0.5; 0.8)
1.0 (0.7; 1.4)
0.8 (0.7; 1.0)
0.7 (0.5; 1.1)
 HVFH
0.7(0.4; 1.4)
0.8 (0.4; 1.1)
0.5 (0.4; 1.0)
0.5 (0.2; 1.2)
Renal VO2 (ml/min per kg)
 CON
0.2 (0.1; 0.2)
0.2 (0.1; 0.2)
0.2 (0.2; 0.2)
0.2 (0.1; 0.2)
 HF
0.2 (0.1; 0.3)
0.2 (0.2; 0.2)
0.2 (0.1; 0.2)
0.2 (0.2; 0.3)
 HVFH
0.1 (0.1; 0.2)
0.2 (0.1; 0.2)
0.1 (0.1; 0.2)
0.1 (0.04; 0.2)
pH RV
 CON
7.50 (7.49; 7.51)
7.42 (7.41; 7.47)a
7.46 (7.43; 7.47)a
7.35 (7.33; 7.39)a
 HF
7.49 (7.41; 7.51)
7.45 (7.44; 7.48)
7.46 (7.40; 7.48)
7.44 (7.37; 7.46)a
 HVFH
7.54 (7.53; 7.54)
7.47 (7.44; 7.51)a
7.43 (7.43; 7.44)a
7.40 (7.31; 7.44)a
Creatinine (μmol/l)
 CON
91 (91; 97)
95 (81; 118)
98 (88; 129)
129 (94; 130)
 HF
86 (79; 98)
84 (75; 95)
75 (62; 77)b
72 (67; 77)b
 HVFH
88 (78; 96)
85 (75; 95)
62 (56; 82)b
62 (51; 78)b
Ileal mucosal microcirculation (MFI)
 CON
3.0 (2.9; 3.0)
2.9 (2.2; 3.0)a
2.4 (2,1; 2,7)a
2.2 (2.0; 2.3)a
 HF
3.0 (2.9; 3.0)
2.4 (1.9; 2.8)a
2.8 (2.5; 3.0)
2.5 (2.4; 2.7)a
 HVFH
3.0 (3.0; 3.0)
3.0 (2.9; 3.0)a
2.3 (2.0; 2.5)a
2.5 (2.3; 2.9)a
Q liver liver blood flow, liver DO 2, liver oxygen delivery, liver VO 2, liver oxygen uptake, pH HV hepatic venous pH, ALT alanine aminotransferase, Q renal artery renal artery blood flow, renal DO 2 renal oxygen delivery, renal VO 2, renal oxygen uptake, pH RV renal venous pH, creatinine serum creatinine levels, MFI mean flow index, CON control group, HF standard haemofiltration group, HVHF high-volume haemofiltration group
aSignificant difference within each group vs. baseline (P < 0.05)
bsignificant intergroup differences at the same time (p < 0.05). Data are median and 25th and 75th quartiles

Inflammation, oxidative/nitrosative stress and endothelial dysfunction (Table 3, Fig. 2 ESM)

Peritonitis-induced septic shock resulted in gradually increased plasma levels of TNF-α and IL-6 (Table 3) and overproduction of nitric oxide, as documented by a significant increase in arterial NOx levels (Fig. 2 ESM). These changes were accompanied by a several-fold increase in TBARS levels and GSH/GSSG ratio (Table 3) providing evidence for oxidative stress and an altered redox status. Conversely, ADMA concentrations decreased during the course of peritonitis (Table 3). Oxidative/nitrosative stress was paralleled by a marked increase in vWf suggesting altered endothelial function (Fig. 2 ESM). Both HF and HVHF did not affect the plasma levels of IL-6. Although HVHF tended to blunt the sepsis-induced increase in TNF-α, none of haemofiltration doses influenced the surrogate markers of oxidative/nitrosative stress and endothelial dysfunction. Likewise, platelet count fell progressively in response to peritonitis in all groups, without intergroup differences (Fig. 2 ESM). In contrast to high plasma levels of both cytokines, the concentrations of IL-6 and of TNF-α in hemofiltrates from both conventional and HVHFs were close to zero (data not shown).
Table 3
Inflammation and oxidative/nitrosative stress
 
Baseline
12 h
18 h
22 h
Plasma IL-6 levels (nmol/g protein)
 CON
115 (70; 205)
555 (361; 650)a
1298 (504; 2405)a
2329 (821; 9805)a
 HF
72 (22; 187)
292 (262; 426)a
1432 (487; 2256)a
978 (786; 4048)a
 HVFH
148 (110; 265)
317 (173; 901)a
567 (312; 2259)a
985 (543; 10771)a
Plasma TNF-α levels (nmol/g protein)
 CON
1 (1; 1)
5 (5; 9)a
11 (6; 18)a
18 (6; 23)a
 HF
1 (0; 2)
5 (3; 7)a
6 (3; 10)a
13 (5; 18)a
 HVFH
2 (0; 2)
3 (2; 8)a
5 (3; 7)a
6 (4; 9)a
Plasma TBARS levels (nmol/g protein)
 CON
19 (15; 22)
47 (38; 60)a
77 (55; 89)a
66 (54; 98)a
 HF
17 (16; 22)
50 (45; 51)a
60 (49; 71)a
72 (53; 88)a
 HVFH
17 (15; 19)
45 (35; 71)a
55 (43; 85)a
53 (42; 80)a
Plasma ADMA levels (nmol/g protein)
 CON
54 (46; 68)
87 (73; 94)
118 (56; 141)
53 (46; 120)
 HF
50 (42; 57)
53 (38; 79)
41 (36; 97)
61 (45; 128)
 HVFH
48 (42; 59)
80 (71; 93)
75 (46; 128)
97 (50; 117)
GSH/GSSG
 CON
9 (7; 10)
15 (12; 25)
25 (13; 33)
142 (30; 375)a
 HF
14 (10; 19)
18 (15; 47)
41 (23; 201)
148 (56; 497)a
 HVFH
10 (8; 12)
32 (13; 33)
28 (22; 63)
106 (28; 204)a
aSignificant difference within each group versus baseline (P < 0.05)
IL-6 interleukin-6, TNF-α tumor necrosis factor alpha, TBARS plasma thiobarbituric acid reactive species, ADMA asymmetric dimethylarginine, GSH/GSSG reduced/oxidized glutathione ratio, CON control group, HF standard haemofiltration group, HVHF high-volume haemofiltration group
aSignificant difference within each group versus baseline (P < 0.05)
In sham-operated animals haemofiltration did not affect hemodynamic, microcirculatory, and metabolic data nor markers of inflammation, oxidative/nitrosative stress and endothelial dysfunction (data not shown).

Discussion

This experimental study evaluated the effects of continuous conventional and HVHF in various biological systems related to multiple pathophysiologic pathways in a porcine model of septic shock. The main findings of the present study were that (1) haemofiltration prevented the progression of septic hypotension within the study period, with the effect being more pronounced in the HVHF group; (2) despite favorable effects on vasopressor requirements, neither of the haemofiltration doses beneficially modulated the sepsis-induced alterations in microcirculatory perfusion and energy metabolism, endothelial dysfunction and oxidative stress.
The reduced need for vasopressor support observed in both haemofiltration groups is consistent with previous experimental [16, 19, 20, 27] and human studies [9, 11, 13, 14]. The unchanged cardiac performance and comparable cardiac preload suggest an influence of haemofiltration on pathways implicated in the control of vascular tone, such as cytokine-driven iNOS-generated overproduction of nitric oxide or opening of ATP-sensitive potassium channels [28, 29]. The former pathway, however, is unlikely since we were unable to demonstrate a clear-cut removal of pro-inflammatory cytokines nor a suppression of excessive NO production, as documented by the absence of an effect on plasma nitrate/nitrite levels. In addition, reactive nitrogen/oxygen species were recently reported to be capable of inducing vascular hyporeactivity and vasodilatory hypotension [3032]. Nevertheless, as haemofiltration failed to affect surrogate markers of sepsis-induced oxidative/nitrosative stress, it seems conceivable to speculate that the better hemodynamic stability was not related to changes in these downstream pathways. One could also argue that the vasopressor-sparing effect of haemofiltration might simply be the result of cooling [33] and/or better acid–base control [34, 35] rather than a mediator-based mechanism. However, we did not observe any obvious differences in body core temperature and systemic pH in septic animals treated with or without haemofiltration. Admittedly, the contribution of cooling effect to the reduced need for vasopressor support cannot be entirely neglected. In support of this notion, we could recently demonstrate that even a mild haemofiltration-induced decrease in core temperature, the extent of which was comparable to this study, had the potential to increase systemic vascular resistance in septic patients [33]. In contrast, Rogiers et al. [36] observed that a decrease in body temperature during haemofiltration resulted in a rapid development of hypotension and hypodynamic circulation in ovine septic shock model. It should be noted, however, that in the Rogiers study the body temperature fell below baseline with the lowest value of 36.1°C, which is in marked contrast to our results. Alternatively, cutting the plasma peak concentrations of cytokines [37] without a measurable effect on plasma cytokines levels or elimination of other unmeasured vasodilatory or inflammatory mediators [9, 3840] could have explained the observed systemic hemodynamic effects of haemofiltration. Finally, removal of sedative drugs leading to an increased sympathetic drive of animals cannot be completely excluded.
The apparent dissociation between the salutary effects of haemofiltration on vasopressor requirement and the totally absent improvement in other biological systems is a striking and key finding of this study. In this context, our experiment is the first and only study so far to assess the effects of haemofiltration on sepsis-mediated disturbances of microvascular perfusion and energy metabolism in different vital organs. Using laser Doppler flowmetry we did not observe any positive impact of haemofiltration on ileal mucosal and renal cortex microvascular perfusion. Since direct visualization of the ileal mucosal microcirculation gave similar results, it is unlikely that we overlooked major microvascular effects. These findings might be of particular importance given the fact that early microcirculatory alterations are related to a poor prognosis in human sepsis [41]. Furthermore, taking into account a hypothesis that haemofiltration may have reduced the burden of various mediators which, in fact, affect cellular metabolism, a concordant amelioration in markers reflecting metabolic stress would have been expected. Nonetheless, the progressive changes in hepato-splanchnic lactate/pyruvate and ketone bodies ratios indicating a deranged cytosolic and mitochondrial redox potential, respectively [42], clearly argue against an improvement in cellular energy balance with haemofiltration. Our results are in sharp contrast to data from Li et al. [43] who demonstrated that HVHF (100 ml/kg per hour) improved myocardial mitochondrial complex I activity in porcine peritonitis. These apparent dissociations are most likely due to the substantial differences in the model and study design used. While animals in the above mentioned study exhibited severe hypodynamic hypotensive shock and were studied within 12 h since the induction of peritonitis, we evaluated the effects of haemofiltration over 22 h of progressive hyperdynamic sepsis. Moreover, the prophylactic timing of intervention (1 h after the insult) and avoidance of vasopressors in the study by Li et al. make both studies difficult to compare. Given the limitations of our methodology, we were unable to determine whether or not the failure of haemofiltration to counteract the sepsis-induced microvascular and metabolic derangements is attributable to the limited capacity of plasma water exchange to affect the tissue or even cellular concentrations of sepsis mediators [4446].
The endothelial cells represent a crucial target organ for the action of inflammatory mediators and are believed to be one of the key elements in the pathophysiology of sepsis [47, 48]. To the best of our knowledge, no data is available to document the capacity of haemofiltration to modulate sepsis-induced endothelial and coagulation dysfunction. In our study haemofiltration did not ameliorate the peritonitis-induced increase in plasma vWf, a generally accepted marker of endothelial injury [49]. Likewise, the progressive fall in platelet count, probably as a result of disseminated intravascular coagulation, was not influenced by haemofiltration. The contribution of the extracorporeal circuit to these changes seems unlikely as haemofiltration did not influence the studied variables in sham-operated animals. These results are corroborated by our clinical study demonstrating that continuous hemodiafiltration neither modified plasma vWf levels nor affected platelet count [50].
While all previous experimental studies compared the effects of HVHF either with untreated subjects or with low-volume haemofiltration (20 ml/kg per hour), our study is the first to seeking whether increasing the dose of plasma water exchange confers an additional benefit over the currently accepted standard haemofiltration dose, i.e. 35 ml/kg per hour. Although our observation corroborates recent reports, both from animal [16, 19, 20, 27] and clinical [914] trials, demonstrating a favorable effect on systemic haemodynamic, an ultrafiltration rate of 100 ml/kg per hour failed to be superior over 35 ml/kg per hour in its capability to ameliorate disturbances in other mutually independent biological systems. These results could indicate, among other things, that the value of haemodynamic improvement as a surrogate marker for efficacy of haemofiltration might be ambiguous. Albeit indirectly, our findings also argue in support of the notion that haemofiltration appears to be the most effective when applied as pre-treatment or concomitantly with the septic or endotoxemic insult [21, 51, 52], which might limit the clinical applicability.
Although our model replicates many of the features of human sepsis, there are some limitations that should be discussed. Antibiotic therapy that would bring the model closer to clinical standard was not used in this model. However, our model was designed to induce hyperdynamic sepsis with increasing severity over time. The antibiotic therapy was expected to blunt the host response to peritonitis, thereby attenuating the development of full manifestation of a true clinical septic response over the 22-h period as used in our experiment. Moreover, the study was not designed to evaluate survival rate but, rather, to focus on different and independent putative biological targets of haemofiltration. Furthermore, we can only speculate whether the observation study time was sufficient for detecting significant changes in the physiological end-points measured. Finally, since the severity of septic shock could be classified as moderate in our model, we cannot exclude different magnitude of the treatment response in more profound shock state.
In summary, in this model of septic shock secondary to peritonitis early HVHF proved superior to standard modality in preventing the development of septic hypotension. Nevertheless, the favorable effects of haemofiltration on vasopressor requirement did not translate into improved microvascular, metabolic and endothelial function, at least within the timeframe of the study and severity of the model.

Acknowledgments

We thank L. Trefil, L. Vit and L. Reifova for their skillful technical assistance. Supported by research project MSM 0021620819 (Replacement of and support to some vital organs).

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://​creativecommons.​org/​licenses/​by-nc/​2.​0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

e.Med Anästhesiologie

Kombi-Abonnement

Mit e.Med Anästhesiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes AINS, den Premium-Inhalten der AINS-Fachzeitschriften, inklusive einer gedruckten AINS-Zeitschrift Ihrer Wahl.

Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Cariou A, Vinsonneau C, Dhainaut JF (2004) Adjunctive therapies in sepsis: an evidence-based review. Crit Care Med 32:S562–S570PubMedCrossRef Cariou A, Vinsonneau C, Dhainaut JF (2004) Adjunctive therapies in sepsis: an evidence-based review. Crit Care Med 32:S562–S570PubMedCrossRef
2.
Zurück zum Zitat Honoré PM, Joannes-Boyau O, Gressens B (2007) Blood and plasma treatments: the rationale of high-volume haemofiltration. Contrib Nephrol 156:387–395PubMedCrossRef Honoré PM, Joannes-Boyau O, Gressens B (2007) Blood and plasma treatments: the rationale of high-volume haemofiltration. Contrib Nephrol 156:387–395PubMedCrossRef
3.
Zurück zum Zitat Bellomo R, Honoré PM, Matson J, Ronco C, Winchester J (2005) Extracorporeal blood treatment (EBT) methods in SIRS/Sepsis. Int J Artif Organs 28:450–458PubMed Bellomo R, Honoré PM, Matson J, Ronco C, Winchester J (2005) Extracorporeal blood treatment (EBT) methods in SIRS/Sepsis. Int J Artif Organs 28:450–458PubMed
4.
Zurück zum Zitat Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, Ronco C (2002) A phase II randomized, controlled trial of continuous haemofiltration in sepsis. Crit Care Med 30:100–106PubMedCrossRef Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, Ronco C (2002) A phase II randomized, controlled trial of continuous haemofiltration in sepsis. Crit Care Med 30:100–106PubMedCrossRef
5.
Zurück zum Zitat Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:26–30PubMedCrossRef Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:26–30PubMedCrossRef
6.
Zurück zum Zitat Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY (2006) Adding a dialysis dose to continuous haemofiltration increases survival in patients with acute renal failure. Kidney Int 70:1312–1317PubMedCrossRef Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY (2006) Adding a dialysis dose to continuous haemofiltration increases survival in patients with acute renal failure. Kidney Int 70:1312–1317PubMedCrossRef
7.
Zurück zum Zitat Schiffl H, Lang SM, Fischer R (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 31:305–310CrossRef Schiffl H, Lang SM, Fischer R (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 31:305–310CrossRef
8.
Zurück zum Zitat Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (2008) The VA/NIH acute renal failure trial network intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20PubMedCrossRef Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P (2008) The VA/NIH acute renal failure trial network intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20PubMedCrossRef
9.
Zurück zum Zitat Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P (2001) High-volume haemofiltration in human septic shock. Intensive Care Med 27:978–986PubMedCrossRef Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P (2001) High-volume haemofiltration in human septic shock. Intensive Care Med 27:978–986PubMedCrossRef
10.
Zurück zum Zitat Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR (2000) Prospective evaluation of short-term, high-volume isovolemic haemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28:3581–3587PubMedCrossRef Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR (2000) Prospective evaluation of short-term, high-volume isovolemic haemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28:3581–3587PubMedCrossRef
11.
Zurück zum Zitat Ratanarat R, Brendolan A, Piccinni P, Dan M, Salvatori G, Ricci Z, Ronco C (2005) Pulse high-volume haemofiltration for treatment of severe sepsis: effects on haemodynamics and survival. Crit Care 9:294–302CrossRef Ratanarat R, Brendolan A, Piccinni P, Dan M, Salvatori G, Ricci Z, Ronco C (2005) Pulse high-volume haemofiltration for treatment of severe sepsis: effects on haemodynamics and survival. Crit Care 9:294–302CrossRef
12.
Zurück zum Zitat Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF (1999) Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 25:814–821PubMedCrossRef Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF (1999) Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med 25:814–821PubMedCrossRef
13.
Zurück zum Zitat Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G (2004) Impact of high volume haemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 50:102–109PubMedCrossRef Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G (2004) Impact of high volume haemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 50:102–109PubMedCrossRef
14.
Zurück zum Zitat Piccinni P, Dan M, Barbacini S, Carraro R, Lieta E, Marafon S, Zamperetti N, Brendolan A, D’Intini V, Tetta C, Bellomo R, Ronco C (2006) Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 32:80–86PubMedCrossRef Piccinni P, Dan M, Barbacini S, Carraro R, Lieta E, Marafon S, Zamperetti N, Brendolan A, D’Intini V, Tetta C, Bellomo R, Ronco C (2006) Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 32:80–86PubMedCrossRef
15.
Zurück zum Zitat Cornejo R, Downey P, Castro R, Romero C, Regueira T, Vega J, Castillo L, Andresen M, Dougnac A, Bugedo G, Hernandez G (2006) High-volume haemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 32:713–722PubMedCrossRef Cornejo R, Downey P, Castro R, Romero C, Regueira T, Vega J, Castillo L, Andresen M, Dougnac A, Bugedo G, Hernandez G (2006) High-volume haemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 32:713–722PubMedCrossRef
16.
Zurück zum Zitat Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL (1992) High volume haemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18:235–240PubMedCrossRef Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL (1992) High volume haemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18:235–240PubMedCrossRef
17.
Zurück zum Zitat Ullrich R, Roeder G, Lorber C, Quezado ZM, Kneifel W, Gasser H, Schlag G, Redl H, Germann P (2001) Continuous venovenous haemofiltration improves arterial oxygenation in endotoxin-induced lung injury in pigs. Anesthesiology 95:428–436PubMedCrossRef Ullrich R, Roeder G, Lorber C, Quezado ZM, Kneifel W, Gasser H, Schlag G, Redl H, Germann P (2001) Continuous venovenous haemofiltration improves arterial oxygenation in endotoxin-induced lung injury in pigs. Anesthesiology 95:428–436PubMedCrossRef
18.
Zurück zum Zitat Yekebas EF, Eisenberger CF, Ohnesorge H, Saalmüller A, Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Strate T, Busch C, Knoefel WT, Bloechle C, Izbicki JR (2001) Attenuation of sepsis-related immunoparalysis by continuous veno-venous haemofiltration in experimental porcine pancreatitis. Crit Care Med 29:1423–1430PubMedCrossRef Yekebas EF, Eisenberger CF, Ohnesorge H, Saalmüller A, Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Strate T, Busch C, Knoefel WT, Bloechle C, Izbicki JR (2001) Attenuation of sepsis-related immunoparalysis by continuous veno-venous haemofiltration in experimental porcine pancreatitis. Crit Care Med 29:1423–1430PubMedCrossRef
19.
Zurück zum Zitat Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B (2000) The effect of intensive plasma water exchange by haemofiltration on haemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 161:1429–1436PubMed Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B (2000) The effect of intensive plasma water exchange by haemofiltration on haemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 161:1429–1436PubMed
20.
Zurück zum Zitat Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL (1999) Continuous venovenous haemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 27:1848–1855PubMedCrossRef Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL (1999) Continuous venovenous haemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 27:1848–1855PubMedCrossRef
21.
Zurück zum Zitat Bouman CS, Oudemans-van Straaten HM, Schultz MJ, Vroom MB (2007) Haemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing. J Crit Care 22:1–12PubMedCrossRef Bouman CS, Oudemans-van Straaten HM, Schultz MJ, Vroom MB (2007) Haemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing. J Crit Care 22:1–12PubMedCrossRef
22.
Zurück zum Zitat Matejovic M, Krouzecky A, Martinkova V, Rokyta R Jr, Kralova H, Treska V, Radermacher P, Novak I (2004) Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock 21:458–465PubMedCrossRef Matejovic M, Krouzecky A, Martinkova V, Rokyta R Jr, Kralova H, Treska V, Radermacher P, Novak I (2004) Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock 21:458–465PubMedCrossRef
23.
Zurück zum Zitat Matejovic M, Krouzecky A, Martinkova V, Rokyta R Jr, Radej J, Kralova H, Treska V, Radermacher P, Novak I (2005) Effects of tempol, a free radical scavenger, on long-term hyperdynamic porcine bacteremia. Crit Care Med 33:1057–1063PubMedCrossRef Matejovic M, Krouzecky A, Martinkova V, Rokyta R Jr, Radej J, Kralova H, Treska V, Radermacher P, Novak I (2005) Effects of tempol, a free radical scavenger, on long-term hyperdynamic porcine bacteremia. Crit Care Med 33:1057–1063PubMedCrossRef
24.
Zurück zum Zitat Matejovic M, Krouzecky A, Rokyta R Jr, Radej J, Kralova H, Treska V, Radermacher P, Novak I (2007) Effects of combining inducible nitric oxide synthase inhibitor and radical scavenger during porcine bacteremia. Shock 27:61–68PubMedCrossRef Matejovic M, Krouzecky A, Rokyta R Jr, Radej J, Kralova H, Treska V, Radermacher P, Novak I (2007) Effects of combining inducible nitric oxide synthase inhibitor and radical scavenger during porcine bacteremia. Shock 27:61–68PubMedCrossRef
25.
Zurück zum Zitat Tugtekin IF, Radermacher P, Theisen M, Matejovic M, Stehr A, Ploner F, Matura K, Ince C, Georgieff M, Träger K (2001) Increased ileal–mucosal–arterial PCO2 gap is associated with impaired villus microcirculation in endotoxic pigs. Intensive Care Med 27:757–766PubMedCrossRef Tugtekin IF, Radermacher P, Theisen M, Matejovic M, Stehr A, Ploner F, Matura K, Ince C, Georgieff M, Träger K (2001) Increased ileal–mucosal–arterial PCO2 gap is associated with impaired villus microcirculation in endotoxic pigs. Intensive Care Med 27:757–766PubMedCrossRef
26.
Zurück zum Zitat De Backer D, Hollenberg S, Boerma C, Goedhart P, Büchele G, Ospina-Tascon G, Dobbe I, Ince C (2007) How to evaluate the microcirculation: report of a round table conference. Crit Care 10;11:R101 De Backer D, Hollenberg S, Boerma C, Goedhart P, Büchele G, Ospina-Tascon G, Dobbe I, Ince C (2007) How to evaluate the microcirculation: report of a round table conference. Crit Care 10;11:R101
27.
Zurück zum Zitat Yekebas EF, Strate T, Zolmajd S, Eisenberger CF, Erbersdobler A, Saalmüller A, Steffani K, Busch C, Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Knoefel WT, Izbicki JR (2002) Impact of different modalities of continuous venovenous haemofiltration on sepsis-induced alterations in experimental pancreatitis. Kidney Int 62:1806–1818PubMedCrossRef Yekebas EF, Strate T, Zolmajd S, Eisenberger CF, Erbersdobler A, Saalmüller A, Steffani K, Busch C, Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Knoefel WT, Izbicki JR (2002) Impact of different modalities of continuous venovenous haemofiltration on sepsis-induced alterations in experimental pancreatitis. Kidney Int 62:1806–1818PubMedCrossRef
28.
Zurück zum Zitat Asfar P, Hauser B, Radermacher P, Matejovic M (2006) Catecholamines and vasopressin during critical illness. Crit Care Clin 22:131–149PubMedCrossRef Asfar P, Hauser B, Radermacher P, Matejovic M (2006) Catecholamines and vasopressin during critical illness. Crit Care Clin 22:131–149PubMedCrossRef
29.
Zurück zum Zitat Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 345:588–595PubMedCrossRef Landry DW, Oliver JA (2001) The pathogenesis of vasodilatory shock. N Engl J Med 345:588–595PubMedCrossRef
30.
Zurück zum Zitat Takakura K, Taniguchi T, Muramatsu I, Takeuchi K, Fukuda S (2002) Modification of alfa-1 adrenoreceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis. Crit Care Med 30:894–899PubMedCrossRef Takakura K, Taniguchi T, Muramatsu I, Takeuchi K, Fukuda S (2002) Modification of alfa-1 adrenoreceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis. Crit Care Med 30:894–899PubMedCrossRef
31.
Zurück zum Zitat Takakura K, Xiaohong W, Takeuchi K, Yasuda Y, Fukuda S (2003) Deactivation of noradrenaline by peroxynitrite as a new pathogenesis in the hypotension of septic shock. Anestesiology 98:928–934CrossRef Takakura K, Xiaohong W, Takeuchi K, Yasuda Y, Fukuda S (2003) Deactivation of noradrenaline by peroxynitrite as a new pathogenesis in the hypotension of septic shock. Anestesiology 98:928–934CrossRef
32.
Zurück zum Zitat Macarthur H, Couri DM, Wilken GH, Westfall TC, Lechner AJ, Matuschak GM, Chen Z, Salvemini D (2003) Modulation of serum cytokine levels by a novel superoxide dismutase mimetic, M40401, in an Escherichia coli model of septic shock: correlation with preserved circulating catecholamines. Crit Care Med 31:237–245PubMedCrossRef Macarthur H, Couri DM, Wilken GH, Westfall TC, Lechner AJ, Matuschak GM, Chen Z, Salvemini D (2003) Modulation of serum cytokine levels by a novel superoxide dismutase mimetic, M40401, in an Escherichia coli model of septic shock: correlation with preserved circulating catecholamines. Crit Care Med 31:237–245PubMedCrossRef
33.
Zurück zum Zitat Rokyta R Jr, Matejovic M, Krouzecky A, Opatrny K Jr, Ruzicka J, Novak I (2004) Effects of continuous venovenous haemofiltration-induced cooling on global haemodynamics, splanchnic oxygen and energy balance in critically ill patients. Nephrol Dial Transplant 19:623–630PubMedCrossRef Rokyta R Jr, Matejovic M, Krouzecky A, Opatrny K Jr, Ruzicka J, Novak I (2004) Effects of continuous venovenous haemofiltration-induced cooling on global haemodynamics, splanchnic oxygen and energy balance in critically ill patients. Nephrol Dial Transplant 19:623–630PubMedCrossRef
34.
Zurück zum Zitat Marsh JD, Margolis TI, Kim D (1988) Mechanism of diminished contractile response to catecholamines during acidosis. Am J Physiol 254:H20–H27PubMed Marsh JD, Margolis TI, Kim D (1988) Mechanism of diminished contractile response to catecholamines during acidosis. Am J Physiol 254:H20–H27PubMed
35.
Zurück zum Zitat Kellum JA, Song M, Venkataraman R (2004) Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest 125:243–248PubMedCrossRef Kellum JA, Song M, Venkataraman R (2004) Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest 125:243–248PubMedCrossRef
36.
Zurück zum Zitat Rogiers P, Sun Q, Dimopoulos G, Tu Z, Pauwels D, Manhaeghe C, Su F, Vincent JL (2006) Blood warming during haemofiltration can improve haemodynamics and outcome in ovine septic shock. Anesthesiology 104:1216–1222PubMedCrossRef Rogiers P, Sun Q, Dimopoulos G, Tu Z, Pauwels D, Manhaeghe C, Su F, Vincent JL (2006) Blood warming during haemofiltration can improve haemodynamics and outcome in ovine septic shock. Anesthesiology 104:1216–1222PubMedCrossRef
37.
Zurück zum Zitat Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, d’Intini V, Bellomo R (2003) Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 27:792–801PubMedCrossRef Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, d’Intini V, Bellomo R (2003) Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 27:792–801PubMedCrossRef
38.
Zurück zum Zitat Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D (1996) Effect of haemofiltration on haemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22:1360–1367PubMedCrossRef Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D (1996) Effect of haemofiltration on haemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22:1360–1367PubMedCrossRef
39.
Zurück zum Zitat Silvester W (1997) Mediator removal with CRRT: complement and cytokines. Am J Kidney Dis 30:S38–S43PubMedCrossRef Silvester W (1997) Mediator removal with CRRT: complement and cytokines. Am J Kidney Dis 30:S38–S43PubMedCrossRef
40.
Zurück zum Zitat Wang Y, Liu Y, Sarker KP, Nakashima M, Serizawa T, Kishida A, Akashi M, Nakata M, Kitajima I, Maruyama I (2000) Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 24(470):151–155 Wang Y, Liu Y, Sarker KP, Nakashima M, Serizawa T, Kishida A, Akashi M, Nakata M, Kitajima I, Maruyama I (2000) Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 24(470):151–155
41.
Zurück zum Zitat Trzeciak S, Dellinger RP, Parrillo JE, Guglielmi M, Bajaj J, Abate NL, Arnold RC, Colilla S, Zanotti S, Hollenberg SM (2007) Microcirculatory alterations in resuscitation and shock investigators early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to haemodynamics, oxygen transport, and survival. Ann Emerg Med 49:88–98PubMedCrossRef Trzeciak S, Dellinger RP, Parrillo JE, Guglielmi M, Bajaj J, Abate NL, Arnold RC, Colilla S, Zanotti S, Hollenberg SM (2007) Microcirculatory alterations in resuscitation and shock investigators early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to haemodynamics, oxygen transport, and survival. Ann Emerg Med 49:88–98PubMedCrossRef
42.
Zurück zum Zitat Leverve XM (1999) From tissue perfusion to metabolic marker: assessing organ competition and co-operation in critically ill patients? Intensive Care Med 25:890–892PubMedCrossRef Leverve XM (1999) From tissue perfusion to metabolic marker: assessing organ competition and co-operation in critically ill patients? Intensive Care Med 25:890–892PubMedCrossRef
43.
Zurück zum Zitat Li CM, Chen JH, Zhang P, He Q, Yuan J, Chen RJ, Cheng XJ, Tan HZ, Yang Y (2007) Continuous veno-venous haemofiltration attenuates myocardial mitochondrial respiratory chain complexes activity in porcine septic shock. Anaesth Intensive Care 35:911–919PubMed Li CM, Chen JH, Zhang P, He Q, Yuan J, Chen RJ, Cheng XJ, Tan HZ, Yang Y (2007) Continuous veno-venous haemofiltration attenuates myocardial mitochondrial respiratory chain complexes activity in porcine septic shock. Anaesth Intensive Care 35:911–919PubMed
44.
Zurück zum Zitat Joannes-Boyau O, Honore PM, Boer W (2006) Haemofiltration: the case for removal of sepsis mediators from where they do harm. Crit Care Med 34:2244–2246PubMedCrossRef Joannes-Boyau O, Honore PM, Boer W (2006) Haemofiltration: the case for removal of sepsis mediators from where they do harm. Crit Care Med 34:2244–2246PubMedCrossRef
45.
Zurück zum Zitat Honoré PM, Matson JR (2004) Extracorporeal removal for sepsis: acting at the tissue level—the beginning of a new era for this treatment modality in septic shock. Crit Care Med 32:896–897PubMedCrossRef Honoré PM, Matson JR (2004) Extracorporeal removal for sepsis: acting at the tissue level—the beginning of a new era for this treatment modality in septic shock. Crit Care Med 32:896–897PubMedCrossRef
46.
Zurück zum Zitat Ronco C (2007) The immunomodulatory effect of extracorporeal therapies in sepsis: a reconciliation of three theories. Int J Artif Organs 30:855–857PubMed Ronco C (2007) The immunomodulatory effect of extracorporeal therapies in sepsis: a reconciliation of three theories. Int J Artif Organs 30:855–857PubMed
47.
Zurück zum Zitat Hack CE, Zeerleder S (2001) The endothelium in sepsis: source of and target for inflammation. Crit Care Med 29:S21–S27PubMedCrossRef Hack CE, Zeerleder S (2001) The endothelium in sepsis: source of and target for inflammation. Crit Care Med 29:S21–S27PubMedCrossRef
48.
Zurück zum Zitat Schouten M, Wiersinga WJ, Levi M, van der Poll T (2008) Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 83:536–545PubMedCrossRef Schouten M, Wiersinga WJ, Levi M, van der Poll T (2008) Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 83:536–545PubMedCrossRef
49.
Zurück zum Zitat Reinhart K, Bayer O, Brunkhorst F, Meisner M (2002) Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 30:S302–S312PubMedCrossRef Reinhart K, Bayer O, Brunkhorst F, Meisner M (2002) Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 30:S302–S312PubMedCrossRef
50.
Zurück zum Zitat Polanska K, Opatrny K Jr, Rokyta R Jr, Krouzecky A, Vit L, Kasal E (2006) Effect of regional citrate anticoagulation on thrombogenicity and biocompatibility during CVVHDF. Ren Fail 28:107–118PubMedCrossRef Polanska K, Opatrny K Jr, Rokyta R Jr, Krouzecky A, Vit L, Kasal E (2006) Effect of regional citrate anticoagulation on thrombogenicity and biocompatibility during CVVHDF. Ren Fail 28:107–118PubMedCrossRef
51.
Zurück zum Zitat Honore’ PM, Joannes-Boyau O, Merson L, Boer W, Piette V, Galloy AC, Janvier G (2006) The big bang of haemofiltration: the beginning of a new era in the third millennium for extra-corporeal blood purification! Int J Artif Organs 29:649–659PubMed Honore’ PM, Joannes-Boyau O, Merson L, Boer W, Piette V, Galloy AC, Janvier G (2006) The big bang of haemofiltration: the beginning of a new era in the third millennium for extra-corporeal blood purification! Int J Artif Organs 29:649–659PubMed
52.
Zurück zum Zitat Mink SN, Li X, Bose D, Gu M, Liu G, Jacobs H, Light RB (1999) Early but not delayed continuous arteriovenous haemofiltration improves cardiovascular function in sepsis in dogs. Intensive Care Med 25:733–743PubMedCrossRef Mink SN, Li X, Bose D, Gu M, Liu G, Jacobs H, Light RB (1999) Early but not delayed continuous arteriovenous haemofiltration improves cardiovascular function in sepsis in dogs. Intensive Care Med 25:733–743PubMedCrossRef
Metadaten
Titel
High versus standard-volume haemofiltration in hyperdynamic porcine peritonitis: effects beyond haemodynamics?
verfasst von
Roman Sykora
Jiri Chvojka
Ales Krouzecky
Jaroslav Radej
Thomas Karvunidis
Veronika Varnerova
Ivan Novak
Martin Matejovic
Publikationsdatum
01.02.2009
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 2/2009
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-008-1318-y

Weitere Artikel der Ausgabe 2/2009

Intensive Care Medicine 2/2009 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.